Skip to main content

Table 1 Details of grade III GCT patients treated with autograft-prosthesis composite

From: Inactivated autograft–prosthesis composite have a role for grade III giant cell tumor of bone around the knee

Site

Pathological fracture

Status of tumor

Follow-up (months)

MSTS function score

ISOLS image score

Status at latest follow-up

Left distal femur

No

Recurrence

67

27 (90%)

33 (92%)

Disease-free

Right distal femur

No

Recurrence

60

26 (87%)

35 (97%)

Disease-free

Left distal femur

Yes

Primary

51

25 (83%)

28 (78%)

Disease-free

Left distal femur

No

Recurrence

48

25 (83%)

31 (86%)

Disease-free

Left distal femur

No

Primary

44

26 (87%)

30 (83%)

Disease-free

Right proximal tibia

No

Recurrence

38

29 (97%)

35 (97%)

Disease-free

Left proximal tibia

No

Primary

48

26 (87%)

30 (83%)

Disease-free

Right proximal tibia

No

Primary

48

27 (90%)

33 (92%)

Disease-free